Stephen Colbert Returns to Late Night Show After Ruptured Appendix
Medically reviewed by Drugs.com.
By Robin Foster HealthDay Reporter
WEDNESDAY, Dec. 13, 2023 -- Comedian Stephen Colbert returned to his popular late night talk show this week after recovering from a ruptured appendix he suffered roughly three weeks ago.
During his monologue on Monday, the talk show host told the audience he was taping back-to-back episodes around Nov. 20 when he experienced almost unbearable pain.
"I was in a heap of trouble," he said.
Band leader Louis Cato added, "I knew something was wrong when, for the first time in almost nine years, you had to rehearse the monologue sitting at the desk with a barf bucket next to you."
Colbert was trying to make up for time lost to a one-week bout with COVID and the five-month writers' strike, NBC News reported.
"The pain was manageable," Colbert said. "It only hurt when I moved. And when I didn’t."
After the taping, Colbert said his driver urged them to head to a hospital, with his wife calling and endorsing the idea.
That's where Colbert was diagnosed with a ruptured appendix, likely the result of viral, bacterial or parasitic infection, or possibly a blockage in the appendix, NBC News reported.
When an appendix bursts or develops holes or tears in its walls, that allows stool, mucus and infection to leak into the belly, according to Johns Hopkins Medicine. Surgery is often necessary to stop or prevent the infection from spreading and becoming deadly.
Recovery, Colbert said, involved potent pain medications, but there was an upside: The comedian noted he lost 14 pounds during the ordeal.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-13 22:15
Read more
- Cognitive Decline Slowed With Cognitive Remediation in At-Risk Adults
- Florida Fails to Pass Amendment Legalizing Recreational Weed
- Trends in Obesity Treatment Show Surge in GLP-1 RAs, Drop in Surgeries
- Total Hip Replacement Revision Rates Vary With Type of Material Used
- How AI Might Help Men Fighting Prostate Cancer
- A Cancer Diagnosis Takes Devastating Toll on Family Finances
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions